Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
September-2014 Volume 34 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2014 Volume 34 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

A potential therapeutic effect of CYP2C8 overexpression on anti-TNF-α activity

Corrigendum in: /10.3892/ijmm.2023.5280
  • Authors:
    • Wanjun Liu
    • Bei Wang
    • Hu Ding
    • Dao Wen Wang
    • Hesong Zeng
  • View Affiliations / Copyright

    Affiliations: The Institute of Hypertension and Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China
    Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].
  • Pages: 725-732
    |
    Published online on: July 9, 2014
       https://doi.org/10.3892/ijmm.2014.1844
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Epoxyeicosatrienoic acids (EETs) are generated from arachidonic acid catalysed by cytochrome P450 (CYP) epoxygenases. In addition to regulating vascular tone EETs may alleviate inflammation and ROS. The present study was conducted to determine whether CYP2C8 gene overexpression was able to increase the level of EETs, and subsequently prevent TNF-α induced inflammation and reactive oxygen species (ROS) in human umbilical vein endothelial cells (HUVECs) and macrophages. Peroxisome proliferator‑activated receptor γ (PPARγ) activation, nuclear factor-κB (NF-κB) activation, endothelial nitric oxide synthase (eNOS) activation, gp-91 activation, and inflammatory cytokine expression were detected by western blot analysis or enzyme-linked immuno­sorbent assay. Intracellular reactive oxygen species (ROS) was measured by flow cytometry, while the migration of vascular smooth muscle cells (VSMCs) was detected by transwell assay. pCMV-mediated CYP2C8 overexpression and its metabolites, EETs, markedly suppressed TNF-α induced inflammatory cytokines IL-6 and MCP-1 expression via the activation of NF-κB and degradation of IκBα. Moreover, pretreatment with 11,12-EET significantly blocked TNF-α-induced ROS production. CYP2C8‑derived EETs also effectively alleviated the migration of VSMCs and improved the function of endothelial cells through the upregulation of eNOS, which was significantly decreased under the stimulation of TNF-α. Furthermore, these protective effects observed were mediated by PPARγ activation. To the best of our knowledge, the results of the present study demonstrated for the first time that CYP2C8-derived EETs exerted antivascular inflammatory and anti-oxidative effects, at least in part, through the activation of PPARγ. Thus, the CYP2C8 gene may be useful in the prevention and treatment of vascular inflammatory diseases.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Ross R: Atherosclerosis - an inflammatory disease. N Engl J Med. 340:115–126. 1999. View Article : Google Scholar

2 

Guzik TJ, Korbut R and Adamek-Guzik T: Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol. 54:469–487. 2003.PubMed/NCBI

3 

Cai H: Hydrogen peroxide regulation of endothelial function: origins, mechanisms, and consequences. Cardiovasc Res. 68:26–36. 2005. View Article : Google Scholar : PubMed/NCBI

4 

Madamanchi NR, Hakim ZS and Runge MS: Oxidative stress in atherogenesis and arterial thrombosisthe disconnect between cellular studies and clinical outcomes. J Thromb Haemost. 3:254–267. 2005. View Article : Google Scholar : PubMed/NCBI

5 

Forstermann U: Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies. Nat Clin Pract Cardiovasc Med. 5:338–349. 2008. View Article : Google Scholar : PubMed/NCBI

6 

Park JG and Oh GT: The role of peroxidases in the pathogenesis of atherosclerosis. BMB Rep. 44:497–505. 2011. View Article : Google Scholar

7 

Cominacini L, Pasini AF, Garbin U, et al: Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-κB through an increased production of intracellular reactive oxygen species. J Biol Chem. 275:12633–12638. 2000.

8 

Miller YI, Viriyakosol S, Binder CJ, Feramisco JR, Kirkland TN and Witztum JL: Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells. J Biol Chem. 278:1561–1568. 2003. View Article : Google Scholar : PubMed/NCBI

9 

Miller YI, Viriyakosol S, Worrall DS, Boullier A, Butler S and Witztum JL: Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages. Arterioscler Thromb Vasc Biol. 25:1213–1219. 2005. View Article : Google Scholar : PubMed/NCBI

10 

Bae YS, Lee JH, Choi SH, et al: Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2. Circ Res. 104:210–218. 2009. View Article : Google Scholar

11 

Forman HJ and Torres M: Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling. Am J Respir Crit Care Med. 166:S4–S8. 2002. View Article : Google Scholar : PubMed/NCBI

12 

Taniyama Y and Griendling KK: Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension. 42:1075–1081. 2003. View Article : Google Scholar : PubMed/NCBI

13 

De Keulenaer GW, Ushio-Fukai M, Yin Q, et al: Convergence of redox-sensitive and mitogen-activated protein kinase signaling pathways in tumor necrosis factor-α-mediated monocyte chemoattractant protein-1 induction in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 20:385–391. 2000.PubMed/NCBI

14 

Hulsmans M and Holvoet P: The vicious circle between oxidative stress and inflammation in atherosclerosis. J Cell Mol Med. 14:70–78. 2010. View Article : Google Scholar : PubMed/NCBI

15 

Sury MD, Frese-Schaper M, Muhlemann MK, et al: Evidence that N-acetylcysteine inhibits TNF-α-induced cerebrovascular endothelin-1 upregulation via inhibition of mitogen- and stress-activated protein kinase. Free Radic Biol Med. 41:1372–1383. 2006.

16 

Yang WS, Lee JM, Han NJ, Kim YJ, Chang JW and Park SK: Mycophenolic acid attenuates tumor necrosis factor-α-induced endothelin-1 production in human aortic endothelial cells. Atherosclerosis. 211:48–54. 2010.

17 

Node K, Huo Y, Ruan X, et al: Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science. 285:1276–1279. 1999. View Article : Google Scholar : PubMed/NCBI

18 

Fisslthaler B, Popp R, Kiss L, et al: Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature. 401:493–497. 1999. View Article : Google Scholar : PubMed/NCBI

19 

Wu S, Chen W, Murphy E, et al: Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes. J Biol Chem. 272:12551–12559. 1997. View Article : Google Scholar : PubMed/NCBI

20 

Zeldin DC, Foley J, Boyle JE, et al: Predominant expression of an arachidonate epoxygenase in islets of Langerhans cells in human and rat pancreas. Endocrinology. 138:1338–1346. 1997. View Article : Google Scholar : PubMed/NCBI

21 

Michaelis UR, Fisslthaler B, Medhora M, Harder D, Fleming I and Busse R: Cytochrome P450 2C9-derived epoxyeicosatrienoic acids induce angiogenesis via cross-talk with the epidermal growth factor receptor (EGFR). FASEB J. 17:770–772. 2003.PubMed/NCBI

22 

Sun J, Sui X, Bradbury JA, Zeldin DC, Conte MS and Liao JK: Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids. Circ Res. 90:1020–1027. 2002. View Article : Google Scholar : PubMed/NCBI

23 

Liu L, Chen C, Gong W, et al: Epoxyeicosatrienoic acids attenuate reactive oxygen species level, mitochondrial dysfunction, caspase activation, and apoptosis in carcinoma cells treated with arsenic trioxide. J Pharmacol Exp Ther. 339:451–463. 2011. View Article : Google Scholar

24 

Wray J and Bishop-Bailey D: Epoxygenases and peroxisome proliferator-activated receptors in mammalian vascular biology. Exp Physiol. 93:148–154. 2008. View Article : Google Scholar : PubMed/NCBI

25 

Wu J, Chen C, Zeng HS and Wang DW: The protective effects of cytochrome P450 gene on atherosclerosis induced by high fat diet in different week old mice. Mol Cardiol Chin. 11:37–41. 2011.

26 

Sun J, Huang SH, Zhu YC, et al: Anti-oxidative stress effects of Herba leonuri on ischemic rat hearts. Life Sci. 76:3043–3056. 2005. View Article : Google Scholar : PubMed/NCBI

27 

Simoncini T, Maffei S, Basta G, et al: Estrogens and glucocorticoids inhibit endothelial vascular cell adhesion molecule-1 expression by different transcriptional mechanisms. Circ Res. 87:19–25. 2000. View Article : Google Scholar : PubMed/NCBI

28 

Liu X, Pan L, Gong Q and Zhu Y: Leonurine (SCM-198) improves cardiac recovery in rat during chronic infarction. Eur J Pharmacol. 649:236–241. 2010. View Article : Google Scholar

29 

Wilson SH, Best PJ, Edwards WD, et al: Nuclear factor-κB immunoreactivity is present in human coronary plaque and enhanced in patients with unstable angina pectoris. Atherosclerosis. 160:147–153. 2002.

30 

Collins T and Cybulsky MI: NF-κB: pivotal mediator or innocent bystander in atherogenesis? J Clin Invest. 107:255–264. 2001.

31 

Brasier AR: The nuclear factor-κB-interleukin-6 signalling pathway mediating vascular inflammation. Cardiovasc Res. 86:211–218. 2010.

32 

Marx N, Duez H, Fruchart JC and Staels B: Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells. Circ Res. 94:1168–1178. 2004. View Article : Google Scholar : PubMed/NCBI

33 

Ricote M, Li AC, Willson TM, Kelly CJ and Glass CK: The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature. 391:79–82. 1998.

34 

Cipollone F, Fazia M, Iezzi A, et al: Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans. Arterioscler Thromb Vasc Biol. 24:1259–1265. 2004. View Article : Google Scholar

35 

Dehmer T, Heneka MT, Sastre M, Dichgans J and Schulz JB: Protection by pioglitazone in the MPTP model of Parkinson’s disease correlates with IκBα induction and block of NF κB and iNOS activation. J Neurochem. 88:494–501. 2004.PubMed/NCBI

36 

Castrillo A and Tontonoz P: PPARs in atherosclerosis: the clot thickens. J Clin Invest. 114:1538–1540. 2004. View Article : Google Scholar : PubMed/NCBI

37 

Wang H, Lin L, Jiang J, et al: Up-regulation of endothelial nitric-oxide synthase by endothelium-derived hyperpolarizing factor involves mitogen-activated protein kinase and protein kinase C signaling pathways. J Pharmacol Exp Ther. 307:753–764. 2003. View Article : Google Scholar

38 

Lee PC, Ho IC and Lee TC: Oxidative stress mediates sodium arsenite-induced expression of heme oxygenase-1, monocyte chemoattractant protein-1, and interleukin-6 in vascular smooth muscle cells. Toxicol Sci. 85:541–550. 2005. View Article : Google Scholar

39 

Zhang T, Zhang X, Yu W, et al: Effects of chemokine-like factor 1 on vascular smooth muscle cell migration and proliferation in vascular inflammation. Atherosclerosis. 226:49–57. 2013. View Article : Google Scholar : PubMed/NCBI

40 

Caglayan E, Romeo GR, Kappert K, et al: Profilin-1 is expressed in human atherosclerotic plaques and induces atherogenic effects on vascular smooth muscle cells. PLoS One. 5:e136082010. View Article : Google Scholar : PubMed/NCBI

41 

Nakagawa M, Ohno T, Maruyama R, et al: Sesquiterpene lactone suppresses vascular smooth muscle cell proliferation and migration via inhibition of cell cycle progression. Biol Pharm Bull. 30:1754–1757. 2007. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Liu W, Wang B, Ding H, Wang DW and Zeng H: A potential therapeutic effect of CYP2C8 overexpression on anti-TNF-α activity Corrigendum in /10.3892/ijmm.2023.5280. Int J Mol Med 34: 725-732, 2014.
APA
Liu, W., Wang, B., Ding, H., Wang, D.W., & Zeng, H. (2014). A potential therapeutic effect of CYP2C8 overexpression on anti-TNF-α activity Corrigendum in /10.3892/ijmm.2023.5280. International Journal of Molecular Medicine, 34, 725-732. https://doi.org/10.3892/ijmm.2014.1844
MLA
Liu, W., Wang, B., Ding, H., Wang, D. W., Zeng, H."A potential therapeutic effect of CYP2C8 overexpression on anti-TNF-α activity Corrigendum in /10.3892/ijmm.2023.5280". International Journal of Molecular Medicine 34.3 (2014): 725-732.
Chicago
Liu, W., Wang, B., Ding, H., Wang, D. W., Zeng, H."A potential therapeutic effect of CYP2C8 overexpression on anti-TNF-α activity Corrigendum in /10.3892/ijmm.2023.5280". International Journal of Molecular Medicine 34, no. 3 (2014): 725-732. https://doi.org/10.3892/ijmm.2014.1844
Copy and paste a formatted citation
x
Spandidos Publications style
Liu W, Wang B, Ding H, Wang DW and Zeng H: A potential therapeutic effect of CYP2C8 overexpression on anti-TNF-α activity Corrigendum in /10.3892/ijmm.2023.5280. Int J Mol Med 34: 725-732, 2014.
APA
Liu, W., Wang, B., Ding, H., Wang, D.W., & Zeng, H. (2014). A potential therapeutic effect of CYP2C8 overexpression on anti-TNF-α activity Corrigendum in /10.3892/ijmm.2023.5280. International Journal of Molecular Medicine, 34, 725-732. https://doi.org/10.3892/ijmm.2014.1844
MLA
Liu, W., Wang, B., Ding, H., Wang, D. W., Zeng, H."A potential therapeutic effect of CYP2C8 overexpression on anti-TNF-α activity Corrigendum in /10.3892/ijmm.2023.5280". International Journal of Molecular Medicine 34.3 (2014): 725-732.
Chicago
Liu, W., Wang, B., Ding, H., Wang, D. W., Zeng, H."A potential therapeutic effect of CYP2C8 overexpression on anti-TNF-α activity Corrigendum in /10.3892/ijmm.2023.5280". International Journal of Molecular Medicine 34, no. 3 (2014): 725-732. https://doi.org/10.3892/ijmm.2014.1844
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team